These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17343311)

  • 1. Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials.
    Maksymowych WP; Landewe R; Boers M; Garnero P; Geusens P; El-Gabalawy H; Heinegard D; Kraus VB; Lohmander S; Matyas J; Saxne T; van der Heijde D
    J Rheumatol; 2007 Mar; 34(3):634-40. PubMed ID: 17343311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
    Maksymowych WP; Fitzgerald O; Wells GA; Gladman DD; Landewé R; Ostergaard M; Taylor WJ; Christensen R; Tak PP; Boers M; Syversen SW; Bathon JM; Ritchlin CJ; Mease PJ; Bykerk VP; Garnero P; Geusens P; El-Gabalawy H; Aletaha D; Inman RD; Kraus VB; Kvien TK; van der Heijde D
    J Rheumatol; 2009 Aug; 36(8):1792-9. PubMed ID: 19671814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.
    Keeling SO; Landewe R; van der Heijde D; Bathon J; Boers M; Garnero P; Geusens P; El-Gabalawy H; Inman RD; Kraus VB; Kvien TK; Mease PJ; Ostergaard M; Ritchlin C; Syversen SW; Maksymowych WP
    J Rheumatol; 2007 Mar; 34(3):623-33. PubMed ID: 17343310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria.
    Maksymowych WP; Landewé R; Tak PP; Ritchlin CJ; Ostergaard M; Mease PJ; El-Gabalawy H; Garnero P; Gladman DD; Fitzgerald O; Aletaha D; Bykerk VP; Bathon JM; Syversen SW; Boers M; Geusens P; Inman RD; Kraus VB; Kvien TK; Taylor WJ; Wells GA; van der Heijde D
    J Rheumatol; 2009 Aug; 36(8):1785-91. PubMed ID: 19671813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis.
    Wallace CA; Ravelli A; Huang B; Giannini EH
    J Rheumatol; 2006 Apr; 33(4):789-95. PubMed ID: 16482643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group).
    Bingham CO; Pohl C; Woodworth TG; Hewlett SE; May JE; Rahman MU; Witter JP; Furst DE; Strand CV; Boers M; Alten RE
    J Rheumatol; 2009 Oct; 36(10):2335-41. PubMed ID: 19684147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers.
    Syversen SW; Landewe R; van der Heijde D; Bathon JM; Boers M; Bykerk VP; Fitzgerald O; Gladman DD; Garnero P; Geusens P; El-Gabalawy H; Inman RD; Kraus V; Kvien TK; Mease PJ; Ostergaard M; Ritchlin CJ; Tak PP; Taylor WJ; Maksymowych WP
    J Rheumatol; 2009 Aug; 36(8):1769-84. PubMed ID: 19671812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome measurements in scleroderma: results from a delphi exercise.
    Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR
    J Rheumatol; 2007 Mar; 34(3):501-9. PubMed ID: 17299843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process.
    Fried BJ; Boers M; Baker PR
    J Rheumatol; 1993 Mar; 20(3):548-51. PubMed ID: 8478870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing single joints in arthritis clinical trials.
    Giles JT; Mease P; Boers M; Bresnihan B; Conaghan PG; Heald A; Maksymowych WP; Maillefert JF; Simon L; Tsuji W; Wakefield R; Woodworth T; Schumacher HR; Bingham CO
    J Rheumatol; 2007 Mar; 34(3):641-7. PubMed ID: 17343312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome evaluations in gout.
    Schumacher HR; Taylor W; Joseph-Ridge N; Perez-Ruiz F; Chen LX; Schlesinger N; Khanna D; Furst DE; Becker MA; Dalbeth N; Edwards NL
    J Rheumatol; 2007 Jun; 34(6):1381-5. PubMed ID: 17552064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.
    Lassere MN; Johnson KR; Boers M; Tugwell P; Brooks P; Simon L; Strand V; Conaghan PG; Ostergaard M; Maksymowych WP; Landewe R; Bresnihan B; Tak PP; Wakefield R; Mease P; Bingham CO; Hughes M; Altman D; Buyse M; Galbraith S; Wells G
    J Rheumatol; 2007 Mar; 34(3):607-15. PubMed ID: 17343307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibromyalgia syndrome.
    Mease P; Arnold LM; Bennett R; Boonen A; Buskila D; Carville S; Chappell A; Choy E; Clauw D; Dadabhoy D; Gendreau M; Goldenberg D; Littlejohn G; Martin S; Perera P; Russell IJ; Simon L; Spaeth M; Williams D; Crofford L
    J Rheumatol; 2007 Jun; 34(6):1415-25. PubMed ID: 17552068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project.
    Maksymowych WP; Gladman D; Rahman P; Boonen A; Bykerk V; Choquette D; Dimond S; Fortin P; Karsh J; Klinkhoff AV; Mosher D; Mulholland K; Olszynski WP; Russell AS; Savage L; Shanner L; Shojania K; Starr M; Thomson G; Zummer M; Inman R;
    J Rheumatol; 2007 Nov; 34(11):2273-84. PubMed ID: 17896800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evidence for magnetic resonance imaging as an outcome measure in proof-of-concept rheumatoid arthritis studies.
    Conaghan PG; McQueen FM; Peterfy CG; Lassere MN; Ejbjerg B; Bird P; O'Connor PJ; Haavardsholm E; Edmonds JP; Emery P; Genant HK; Ostergaard M;
    J Rheumatol; 2005 Dec; 32(12):2465-9. PubMed ID: 16331788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.
    Evers S; Goossens M; de Vet H; van Tulder M; Ament A
    Int J Technol Assess Health Care; 2005; 21(2):240-5. PubMed ID: 15921065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments.
    Mokkink LB; Terwee CB; Knol DL; Stratford PW; Alonso J; Patrick DL; Bouter LM; de Vet HC
    BMC Med Res Methodol; 2006 Jan; 6():2. PubMed ID: 16433905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
    Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
    Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.